The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhoea
- PMID: 15529609
The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhoea
Abstract
Background: Chronic functional diarrhea is an embarrassing symptom, causing the impairment of the quality of life.
Aim: We looked for the effect of two antidiarrheal drugs, diosmectite and loperamide on the psychosocial adjustment to illness, a predictor for the health-related quality of life, in chronic functional diarrhea.
Methods: Prospective controlled randomized trial including 50 consecutive patients with chronic functional diarrhea. They received either diosmectite 3 g b.i.d (n=25, 11M/14F, age 43+/-12 years) or loperamide 2 mg b.i.d. (n=25, 12M/13F, 47+/-11 years) for 2 weeks. Diarrhea and four other digestive symptoms were evaluated on a 0-16 scale, as well as patient's satisfaction (scale 1-10) and physician's satisfaction (scale 0-4). Psychosocial adjustment to illness was assessed with the PAIS-SR scale.
Results: Symptom score for diarrhea was reduced from 10.5+/-5.7 to 2.6+/-1.2 (mean+/-SD), p<0.001 by diosmectite and from 8.5+/-4.2 to 1.2+/-0.6, p<0.0001 by loperamide. Diosmectite had a stronger effect than loperamide on accompanying pain (p<0.05) and bloating (p<0.01), but not on nausea, anorexia and emesis. The overall ratings of the patient's satisfaction (8.7+/-0.9 vs. 8.2+/-1.1, NS) and physician's satisfaction (3.2+/-0.3 vs. 3.1+/-0.4, NS) were similar. Psychological adjustment to illness was not changed for following items: health care orientation and domestic environment. Diosmectite improved more than loperamide the psychological distress (from 12.7+/-3.8 to 7.7+/-2.1 vs. 11.8+/-3.3 to 9.05+/-2.2, p<0.05), vocational environment (from 3.2+/-1.1 to 2.2+/-1.2 vs. 3.3+/-1.2 to 3.4+/-1.5, p<0.05) and sexual relationship scores (from 6.4+/-2.2 to 3.0+/-1.5 vs. 7.2+/-2.2 to 5.5+/-2.1, p<0.05). Both drugs similarly improved the items: family relationship and social environment.
Conclusions: Diosmectite and loperamide are both potent drugs for chronic functional diarrhea. Diosmectite has better effects on associated symptoms and some items of psychosocial adjustment to illness (distress, sexual activity and vocational environment).
Similar articles
-
The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.Rom J Intern Med. 2006;44(3):273-80. Rom J Intern Med. 2006. PMID: 18386606 Clinical Trial.
-
Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.Clin Ther. 2004 Oct;26(10):1644-51. doi: 10.1016/j.clinthera.2004.10.001. Clin Ther. 2004. PMID: 15598481 Clinical Trial.
-
Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.Clin Gastroenterol Hepatol. 2009 Apr;7(4):456-62. doi: 10.1016/j.cgh.2008.12.007. Epub 2008 Dec 13. Clin Gastroenterol Hepatol. 2009. PMID: 19268266 Clinical Trial.
-
The role of loperamide in gastrointestinal disorders.Rev Gastroenterol Disord. 2008 Winter;8(1):15-20. Rev Gastroenterol Disord. 2008. PMID: 18477966 Review.
-
[Antidiarrheal drugs for chronic diarrhea].Dtsch Med Wochenschr. 2013 Nov;138(45):2309-12. doi: 10.1055/s-0033-1349597. Epub 2013 Oct 25. Dtsch Med Wochenschr. 2013. PMID: 24163167 Review. German.
Cited by
-
mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?Br J Clin Pharmacol. 2006 Jan;61(1):27-30. doi: 10.1111/j.1365-2125.2005.02505.x. Br J Clin Pharmacol. 2006. PMID: 16390348 Free PMC article. Clinical Trial.
-
Long-term diosmectite use does not alter the gut microbiota in adults with chronic diarrhea.BMC Microbiol. 2022 Feb 12;22(1):54. doi: 10.1186/s12866-022-02464-7. BMC Microbiol. 2022. PMID: 35151268 Free PMC article.
-
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13. United European Gastroenterol J. 2022. PMID: 35695704 Free PMC article. Review.
-
Agents that act luminally to treat diarrhoea and constipation.Nat Rev Gastroenterol Hepatol. 2012 Nov;9(11):661-74. doi: 10.1038/nrgastro.2012.162. Epub 2012 Sep 4. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22945441 Review.
-
Pharmacologic Agents for Chronic Diarrhea.Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15. Intest Res. 2015. PMID: 26576135 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous